Promius Pharma, LLC-Product Pipeline Review-2015

Promius Pharma, LLC-Product Pipeline Review-2015

  • Products Id :- GMDHC07520CDB
  • |
  • Pages: 46
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Promius Pharma, LLC-Product Pipeline Review-2015


Global Markets Direct's, 'Promius Pharma, LLC-Product Pipeline Review-2015', provides an overview of the Promius Pharma, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Promius Pharma, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Promius Pharma, LLC including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Promius Pharma, LLC's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Promius Pharma, LLC's pipeline products

Reasons To Buy

Evaluate Promius Pharma, LLC's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Promius Pharma, LLC in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Promius Pharma, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Promius Pharma, LLC and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Promius Pharma, LLC

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Promius Pharma, LLC and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Promius Pharma, LLC Snapshot 6

Promius Pharma, LLC Overview 6

Key Information 6

Key Facts 6

Promius Pharma, LLC-Research and Development Overview 7

Key Therapeutic Areas 7

Promius Pharma, LLC-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Promius Pharma, LLC-Pipeline Products Glance 12

Promius Pharma, LLC-Late Stage Pipeline Products 12

Pre-Registration Products/Combination Treatment Modalities 12

Phase III Products/Combination Treatment Modalities 13

Promius Pharma, LLC-Clinical Stage Pipeline Products 14

Phase II Products/Combination Treatment Modalities 14

Phase I Products/Combination Treatment Modalities 15

Promius Pharma, LLC-Early Stage Pipeline Products 16

Preclinical Products/Combination Treatment Modalities 16

Promius Pharma, LLC-Drug Profiles 17

DFD-01 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

DFN-11 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

tetracycline MR 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

DFD-06 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

DFD-10 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

ACT-01 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

DFN-10 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

DFD-04 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

DFD-05 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

DFD-07 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

DFD-08 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

DFN-14 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

DFN-19 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Small Molecules 1 for Epilepsy 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Small Molecules 1 for Parkinson's Disease 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Small Molecules 2 for Epilepsy 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

Small Molecules 2 for Parkinson's Disease 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

Small Molecules 3 for Epilepsy 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

Small Molecules 3 for Parkinson's Disease 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

Small Molecules 4 for Epilepsy 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

Small Molecules 4 for Parkinson's Disease 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

Promius Pharma, LLC-Pipeline Analysis 38

Promius Pharma, LLC-Pipeline Products by Target 38

Promius Pharma, LLC-Pipeline Products by Route of Administration 39

Promius Pharma, LLC-Pipeline Products by Molecule Type 40

Promius Pharma, LLC-Pipeline Products by Mechanism of Action 41

Promius Pharma, LLC-Recent Pipeline Updates 42

Promius Pharma, LLC-Dormant Projects 43

Promius Pharma, LLC-Locations And Subsidiaries 44

Head Office 44

Appendix 45

Methodology 45

Coverage 45

Secondary Research 45

Primary Research 45

Expert Panel Validation 45

Contact Us 45

Disclaimer 46

List of Tables

Promius Pharma, LLC, Key Information 6

Promius Pharma, LLC, Key Facts 6

Promius Pharma, LLC-Pipeline by Indication, 2015 8

Promius Pharma, LLC-Pipeline by Stage of Development, 2015 10

Promius Pharma, LLC-Monotherapy Products in Pipeline, 2015 11

Promius Pharma, LLC-Pre-Registration, 2015 12

Promius Pharma, LLC-Phase III, 2015 13

Promius Pharma, LLC-Phase II, 2015 14

Promius Pharma, LLC-Phase I, 2015 15

Promius Pharma, LLC-Preclinical, 2015 16

Promius Pharma, LLC-Pipeline by Target, 2015 38

Promius Pharma, LLC-Pipeline by Route of Administration, 2015 39

Promius Pharma, LLC-Pipeline by Molecule Type, 2015 40

Promius Pharma, LLC-Pipeline Products by Mechanism of Action, 2015 41

Promius Pharma, LLC-Recent Pipeline Updates, 2015 42

Promius Pharma, LLC-Dormant Developmental Projects,2015 43

List of Figures

Promius Pharma, LLC-Pipeline by Top 10 Indication, 2015 8

Promius Pharma, LLC-Pipeline by Stage of Development, 2015 10

Promius Pharma, LLC-Monotherapy Products in Pipeline, 2015 11

Promius Pharma, LLC-Pipeline by Top 10 Target, 2015 38

Promius Pharma, LLC-Pipeline by Top 10 Route of Administration, 2015 39

Promius Pharma, LLC-Pipeline by Top 10 Molecule Type, 2015 40

Promius Pharma, LLC-Pipeline Products by Top 10 Mechanism of Action, 2015 41

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Promius Pharma, LLC; Promius Pharma, LLC - Key Therapeutics; Promius Pharma, LLC - Pipeline Overview and Promising Molecules; Promius Pharma, LLC - News; Promius Pharma, LLC - Latest Updates; Promius Pharma, LLC - Pipeline; Promius Pharma, LLC - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 97500
Site License
USD 3000 INR 195000
Corporate User License
USD 4500 INR 292500



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@]